Analysis | Metabolite Name | Measured Value | Units | subject type |
---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+CL)- | 1849 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+CL)- | 3723 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+CL)- | 9707 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+CL)- | Peak area | Healthy control | |
Reversed phase NEGATIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+CL)- | Peak area | Mild disease | |
Reversed phase NEGATIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+CL)- | Peak area | Severe disease | |
Reversed phase NEGATIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+HCOO)- | 1847 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+HCOO)- | 5331 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+HCOO)- | 9569 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+HCOO)- | 25991 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+HCOO)- | Peak area | Healthy control | |
Reversed phase NEGATIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+HCOO)- | Peak area | Mild disease | |
Reversed phase NEGATIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+HCOO)- | Peak area | Severe disease | |
Reversed phase POSITIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+NA)+ | 17058 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+NA)+ | Peak area | Healthy control | |
Reversed phase POSITIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+NA)+ | Peak area | Mild disease | |
Reversed phase POSITIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+NA)+ | Peak area | Severe disease |